Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-16

Clinical Trial Update: Tamsulosin to Prevent Postoperative Urinary Retention in Laparoscopic Inguinal Hernia Repair [Phase 4]

View source ↗

Summary

Phase 4 trial investigating tamsulosin to prevent postoperative urinary retention during laparoscopic inguinal hernia repair was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamsulosin (tamsulosin)

Snippet

Sponsor: Jewish Hospital, Cincinnati, Ohio | Conditions: Post Operative Urinary Retention | Phase 4 | Status: TERMINATED